Product Program year 2025 Source: CMS Open Payments

BioMimics 3D Vascular Stent System

Device vascular stent

Open in the dashboard

General payments

$1,066,768

1,782 payments

Research payments

$1,311,940

372 payments

Through program year 2025, $1,066,768 in general payments and $1,311,940 in research payments were reported against BioMimics 3D Vascular Stent System (vascular stent).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $470,504 373
2025 Research $72,998 46
2024 General $359,173 278
2024 Research $166,747 85
2023 General $119,278 424
2023 Research $278,286 140
2022 General $117,813 707
2022 Research $793,908 101

Breakdown

Who paid General payments · program years 2022–2025
  1. Veryan Medical Incorporated $1,066,768 1,782 payments
Top recipients General payments · program year 2025
  1. Bret Wiechmann Vascular & Interventional Radiology · Gainesville, FL $374,433 80% · 115 payments
  2. Gary Ansel Interventional Cardiology · Columbus, OH $81,476 17% · 8 payments
  3. Sameer Nagpal Interventional Cardiology · New Haven, CT $2,142 <1% · 3 payments
  4. Miltiadis Leon Interventional Cardiology · San Angelo, TX $1,168 <1% · 20 payments
  5. Christopher Lesar Vascular Surgery · Chattanooga, TN $940 <1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $375,616 80% · 23 practitioners
  2. Interventional Cardiology Internal Medicine $87,757 19% · 19 practitioners
  3. Vascular Surgery Surgery $4,970 1% · 61 practitioners
  4. Surgery $467 <1% · 7 practitioners
  5. Diagnostic Radiology Radiology $414 <1% · 14 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $375,407 80% · 6 recipients
  2. Ohio $81,520 17% · 2 recipients
  3. Texas $3,854 <1% · 27 recipients
  4. Connecticut $3,069 <1% · 8 recipients
  5. Massachusetts $2,146 <1% · 31 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,782 general · 372 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record